Digital Health March 26, 2024
Roche has developed a continuous glucose monitor with predictive algorithms that gives patients with diabetes a way of managing their condition and reducing uncertainty, with a potentially powerful impact on their quality of life.
Roche unveiled the Accu-Chek SmartGuide CGM device, which is not yet available on the market, earlier this month at the 17th annual conference on Advanced Technologies and Treatments for Diabetes in Florence.
The device presents a retrospective and current view on glucose values and estimates trends, as well as indicating the risk of hypoglycaemia in the next 30 minutes and continually forecasting how glucose will develop in the next two hours. It also estimates the risk of nocturnal hypoglycaemia.
“This empowers...
Today's Sponsors
Today's Sponsor